Association between posterior uveal melanoma and iris freckles, iris naevi, and choroidal naevi

British Journal of Ophthalmology

Volumn 88, Issue 1, 2004, Pages 36-38

  Harbour, J W ^a,b   Brantley Jr , M A ^a   Hollingsworth, H ^a   Gordon, M ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHOROID MELANOMA; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; EYE COLOR; FEMALE; HUMAN; HUMAN TISSUE; IRIS MELANOMA; LENTIGO; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RECORDING; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; CHOROID NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRIS DISEASES; IRIS NEOPLASMS; MALE; MELANOMA; MELANOSIS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEVUS; PROSPECTIVE STUDIES; UVEAL NEOPLASMS;

EID: 0347755362     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.88.1.36     Document Type: Article

References (18)

1. Egan KM, Seddon JM, Glynn RJ, et al. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988;32:239-51.
2. Scotto J, Fraumeni JF Jr, Lee JA. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 1976;56:489-91.
3. Rodenas JM, Delgado-Rodriguez M, Herranz MT, et al. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population. Cancer Causes Control 1996;7:275-83.
4. Evans RD, Kopf AW, Lew RA, et al. Risk factors for the development of malignant melanoma-I: Review of case-control studies. J Dermatol Surg Oncol 1988;14:393-408.
5. Marrett LD, King WD, Walter SD, et al. Use of host factors to identify people at high risk for cutaneous malignant melanoma. Cmaj 1992;147:445-53.
6. Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997;73:198-203.
7. Vajdic CM, Kricker A, Giblin M, et al. Eye color and cutaneous nevi predict risk of ocular melanoma in Australia. Int J Cancer 2001;92:906-12.
8. Bataille V, Sasieni P, Cuzick J, et al. Risk of ocular melanoma in relation to cutaneous and iris naevi. Int J Cancer 1995;60:622-6.
9. Seddon JM, Gragoudas ES, Glynn RJ, et al. Host factors, UV radiation, and risk of uveal melanomo. A case-control study. Arch Ophthalmol 1990;108:1274-80.
10. van Hees CL, de Boer A, Jager MJ, et al. Are atypical nevi a risk factor for uveal melanoma? A case-control study. J Invest Dermatol 1994;103:202-5.
11. Reese AG. Pigment freckles of the iris (benign melanomas): their significance in relation to malignant melanoma of the uvea. Am J Ophthalmol 1944;27:217-26.
12. Wilder HC. Relationship of pigment cell clusters in the iris to malignant melanoma of the uveal tract. Bull NY Acad Sci 1948;4:137-42.
13. Horn EP, Hartge P, Shields JA, et al. Sunlight and risk of uveal melanoma. J Natl Cancer Inst 1994;86:1476-8.
14. Michelson JB, Shields JA. Relationship of iris nevi to malignant melanoma of the uvea. Am J Ophthalmol 1977;83:694-6.
15. Tucker MA, Hartge P, Shields JA. Epidemiology of intraocular melanoma. Recent Results Cancer Res 1986;102:159-65.
16. Hale PN, Allen RA, Straatsma BR. Benign melanomas (nevi) of the choroid and ciliary body. Arch Ophthalmol 1965;74:532-8.
17. Ganley JP, Comstock GW. Benign nevi and malignant melanomas of the choroid. Am J Ophthalmol 1973;76:19-25.
18. Grulich AE, Bataille V, Swerdlow AJ, et al. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer 1996;67:485-91.